⌘K

Login Start Free

Home/Filings/4/0001415889-25-006036

4//SEC Filing

Graef Thorsten 4

Accession 0001415889-25-006036

CIK 0001817241other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 5:15 PM ET

Size

4.8 KB

Accession

0001415889-25-006036

Insider Transaction Report

Form 4

Period: 2025-02-26

Artiva Biotherapeutics, Inc.ARTV

Chief Medical Officer

Transactions

Award
Common Stock
2025-02-26+60,000→ 80,000 total

Footnotes (1)

[F1]Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.

Documents

1 file

4
form4-02282025_050209.xmlPrimary

Issuer

Artiva Biotherapeutics, Inc.

CIK 0001817241

Entity typeother

Related Parties

1

filerCIK 0001581192

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 5:15 PM ET
Size: 4.8 KB

View on SEC.gov